Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1159-02
Published December 28, 2016 · Recall initiated: August 4, 2016
Summary
FDA records drug Class I recall D-0218-2017, published December 28, 2016 and initiated August 4, 2016. Recalling firm: Hospira Inc., A Pfizer Company; Status: Ongoing; Reported quantity: 143,250 vials; Lot: Lot # 59064DK, Exp. 11/17. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial.
What to do
Voluntary: Firm initiated · Letter
Get an email if BUPIVACAINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- BUPIVACAINE HYDROCHLORIDE
- Manufacturer
- Hospira Inc., A Pfizer Company
- Distributor
- Nationwide
- Lot
- Lot # 59064DK, Exp. 11/17
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABupivacaine Hydrochloride 0.75% in 8.25% Dextrose Injection, USP (15 mg/2 mL) (7.5 mg/mL) ampules, Rx only,April 22, 2026
- FDABupivacaine HCl Injection, single dose vial, Preservative Free 0.5%, 10mL (25/ct), Rx only, Manufacturer:June 15, 2022
- FDABupivacaine Hydrochloride, USP 0.5% (5mg/mL), 25 vials x 50 mL per box, Rx only, MFG: Pfizer, NDC 0409-1163-01June 15, 2022
- FDAGlucaGen HypoKit (glucagon [rDNA origin] for injection), 1 mg per vial, Single use only, Rx Only, ManufacturedDecember 28, 2016
- FDADocusate Oral 10 mg/mL Oral Syringe, packaged in a) 1 mL (62295-0601-01), b) 2 mL ( 62295-0601-02), and c) 5December 28, 2016
- FDABupivacaine HCl Inj., USP, 0.5% (5 mg/mL), 30 mL Single-dose Preservative-Free, For Nerve Block, Caudal, andSeptember 24, 2014
Questions about this recall
Was Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1159-02 recalled?
Yes. FDA published recall D-0218-2017 on December 28, 2016. Reported hazard: Presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: BUPIVACAINE HYDROCHLORIDE.